Earnings Feed
Start Free
Centessa Pharmaceuticals plc·4

Feb 3, 6:59 PM ET

HUSSAIN IQBAL J 4

Research Summary

AI-generated summary

Updated

Centessa (CNTA) Chief Legal Officer Hussain Iqbal Sells Shares, Receives RSUs

What Happened
Hussain Iqbal, Centessa Pharmaceuticals' Chief Legal Officer, sold a total of 47,741 Centessa shares in late Jan–early Feb 2026 for aggregate proceeds of about $1,196,073, and received 220,000 new equity awards (RSUs/options) the same period. Sales included open-market transactions and a disposition to cover tax/option exercise-related obligations; the awards consist of RSUs and a derivative option grant with a multi-month vesting schedule.

Key Details

  • Transactions and amounts:
    • 2026-01-30: Sold 1,010 shares at $25.01 — $25,261.
    • 2026-02-01: 7,780 shares disposed at $24.57 to cover exercise price/tax — $191,155 (tax/withholding).
    • 2026-02-02: Sold 38,951 shares at a weighted average $25.15 — $979,657. (Weighted-price ranges disclosed in filing.)
    • 2026-02-02: Awarded 40,000 RSUs (no cash cost) — vesting in four equal annual installments beginning Feb 2, 2027.
    • 2026-02-02: Awarded 20,000 RSUs (no cash cost) — vests on Feb 2, 2027.
    • 2026-02-02: Awarded 160,000 derivative shares (option/award) — vests 1/48th monthly starting Mar 2, 2026.
  • Total sold: 47,741 shares for ~$1.20M; total awards received: 220,000 shares (RSUs/options).
  • Footnotes of interest:
    • Some shares may be represented by American Depositary Shares (ADS) (each ADS currently = one Ordinary Share).
    • Several sale prices are reported as weighted averages; the filing offers ranges and says the reporting person will provide per-price breakdown on request.
    • 7,780-share disposition was to cover tax withholding related to vesting.
  • Shares owned after the transactions: not specified in the data provided.
  • Filing/timeliness: Filing date shown as Feb 3, 2026. No explicit late-filing indicator was provided in the supplied details.

Context

  • These transactions combine routine sales (open-market) and company compensation (RSU/option grants). The 7,780-share disposition was a tax/withholding action (common when RSUs vest), while the larger awards are forward-looking compensation that vest over time — the 40k RSUs vest annually, the 20k RSUs vest on a single date, and the 160k option-style award vests monthly (1/48th).
  • Sales do not necessarily indicate a change in sentiment; awards and vesting schedules can drive sales for tax or liquidity reasons. Purchases (not present here) tend to be more direct bullish signals.